Wenming Chen

4.3k total citations
95 papers, 3.3k citations indexed

About

Wenming Chen is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Wenming Chen has authored 95 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 26 papers in Cancer Research and 24 papers in Hematology. Recurrent topics in Wenming Chen's work include Multiple Myeloma Research and Treatments (22 papers), Cancer-related molecular mechanisms research (20 papers) and Legume Nitrogen Fixing Symbiosis (19 papers). Wenming Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Cancer-related molecular mechanisms research (20 papers) and Legume Nitrogen Fixing Symbiosis (19 papers). Wenming Chen collaborates with scholars based in China, Taiwan and United Kingdom. Wenming Chen's co-authors include Tongpeng Xu, Rui Xia, Erbao Zhang, Euan K. James, Wei De, Janet I. Sprent, Ming Sun, Mingde Huang, Yongqian Shu and Geoffrey N. Elliott and has published in prestigious journals such as Blood, Applied and Environmental Microbiology and Analytical Biochemistry.

In The Last Decade

Wenming Chen

85 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenming Chen China 27 1.8k 1.5k 1.2k 352 336 95 3.3k
Mark R. Schmitt United States 28 1.1k 0.6× 418 0.3× 988 0.8× 106 0.3× 76 0.2× 63 2.8k
Yingying Xing China 31 815 0.5× 423 0.3× 740 0.6× 192 0.5× 69 0.2× 79 2.7k
Xin Wei China 34 1.3k 0.7× 328 0.2× 2.0k 1.7× 147 0.4× 82 0.2× 108 3.1k
S Samuel Yang China 24 889 0.5× 145 0.1× 1.0k 0.9× 160 0.5× 80 0.2× 66 2.3k
Chew Yee Ngan United States 28 1.9k 1.1× 497 0.3× 599 0.5× 27 0.1× 126 0.4× 47 2.9k
Yafang Wang China 23 813 0.5× 234 0.2× 639 0.5× 170 0.5× 87 0.3× 65 1.8k
Juan Sun China 28 1.1k 0.6× 289 0.2× 618 0.5× 46 0.1× 33 0.1× 130 2.5k
Darren Heavens United Kingdom 23 1.1k 0.6× 229 0.2× 643 0.5× 37 0.1× 283 0.8× 41 2.2k
François Lefort Switzerland 28 890 0.5× 412 0.3× 1.7k 1.4× 36 0.1× 225 0.7× 123 2.8k

Countries citing papers authored by Wenming Chen

Since Specialization
Citations

This map shows the geographic impact of Wenming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenming Chen more than expected).

Fields of papers citing papers by Wenming Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenming Chen. The network helps show where Wenming Chen may publish in the future.

Co-authorship network of co-authors of Wenming Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wenming Chen. A scholar is included among the top collaborators of Wenming Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenming Chen. Wenming Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Li, Jingjing Deng, Yuan Jian, Zhiyao Zhang, & Wenming Chen. (2025). Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?. Blood Research. 60(1). 11–11.
2.
Nagarajan, Chandramouli, Gin Gin Gan, Chor Sang Chim, et al.. (2025). Imaging in plasma cell disorders—consensus recommendations of the Asian myeloma network bone imaging workgroup. The Lancet Regional Health - Western Pacific. 59. 101597–101597.
4.
Aoki, Naomi, Wenming Chen, Wee Joo Chng, et al.. (2024). The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR). BMC Medical Research Methodology. 24(1). 102–102.
5.
Zhou, Huixing, Yuan Jian, Juan Du, et al.. (2023). Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer Medicine. 12(8). 9085–9096. 2 indexed citations
6.
Chen, Wenming, et al.. (2023). lncRNA UCA1 regulates miR-132/Lrrfip1 axis to promote vascular smooth muscle cell proliferation. Open Medicine. 18(1). 20230738–20230738. 2 indexed citations
7.
Jian, Yuan, Huixing Zhou, Yidan Wang, et al.. (2022). Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients. Cancer Medicine. 11(22). 4182–4192. 5 indexed citations
10.
Gao, Wen, Juan Du, Junru Liu, et al.. (2020). What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?. Frontiers in Oncology. 10. 538126–538126. 12 indexed citations
11.
Gao, Wen, Jie Li, Yuan Jian, et al.. (2018). Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation. International Journal of Hematology. 109(2). 169–174. 11 indexed citations
12.
Heenan, Peter B., Sofie E. De Meyer, T.K. James, et al.. (2017). Genetic diversity and nitrogen fixation of mesorhizobia symbionts of New Zealand endemic Sophora species. New Zealand Journal of Botany. 55(4). 466–478. 8 indexed citations
13.
Cui, Hongxia, et al.. (2017). A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma. Cancer Medicine. 6(12). 2932–2941. 83 indexed citations
14.
Huang, Mingde, Wenming Chen, Fuzhen Qi, et al.. (2015). Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2. Journal of Hematology & Oncology. 8(1). 119 indexed citations
15.
Huang, Mingde, Wenming Chen, Fuzhen Qi, et al.. (2015). Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2. Journal of Hematology & Oncology. 8(1). 50–50. 141 indexed citations
16.
Ridgway, Hayley J., T.K. James, Euan K. James, et al.. (2014). Burkholderia sp. Induces Functional Nodules on the South African Invasive Legume Dipogon lignosus (Phaseoleae) in New Zealand Soils. Microbial Ecology. 68(3). 542–555. 41 indexed citations
17.
Yang, Jing-Iong, et al.. (2011). Cloning and characterization of β-agarase AgaYT from Flammeovirga yaeyamensis strain YT. Journal of Bioscience and Bioengineering. 112(3). 225–232. 30 indexed citations
18.
Wu, Henry C., Wenming Chen, Jih‐Terng Wang, et al.. (2007). The black disease of reef-building corals at green island, Taiwan : Outbreak of a cyanobacteriosponge, Terpios hoshinota (suberitidae; hadromerida). Zoological studies. 46(520). 520–520. 39 indexed citations
19.
Sheu, Shih‐Yi, Wenming Chen, & Guang-Huey Lin. (2006). Characterization and application of a rolling-circle-type plasmid from Cupriavidus taiwanensis. Plasmid. 57(3). 275–285. 4 indexed citations
20.
Vandamme, Peter, Johan Goris, Wenming Chen, Paul de Vos, & Anne Willems. (2002). Burkholderia tuberum sp. nov. and Burkholderia phymatum sp. nov., Nodulate the Roots of Tropical Legumes. Systematic and Applied Microbiology. 25(4). 507–512. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026